Salmonella Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

The Global Salmonella Testing Market is projected to expand from USD 3.31 Billion in 2025 to USD 4.72 Billion by 2031, registering a CAGR of 6.09%. This market encompasses diagnostic technologies, consumables, and procedural methods designed to identify Salmonella bacteria across food items, beverages, water sources, and clinical samples. Key factors driving this growth include increasingly strict international food safety laws, a growing global frequency of foodborne illness outbreaks, and escalating consumer insistence on transparent food hygiene practices. Consequently, rigorous pathogen screening is mandated throughout the supply chain, creating a critical need for dependable and fast detection solutions to avert contamination and safeguard public health.

Despite these growth prospects, the market encounters significant obstacles due to the substantial operational costs tied to advanced molecular diagnostic platforms, which limit adoption in cost-sensitive developing areas. Data from the National Chicken Council in 2024 revealed that 97 percent of whole birds and 93 percent of chicken parts tested negative for Salmonella at processing facilities, demonstrating the immense volume of testing required to uphold these safety levels. While these results highlight the industry's dependence on continuous verification, the financial strain associated with such comprehensive testing programs continues to act as a formidable barrier for smaller market participants.

Market Drivers

The enforcement of rigorous government food safety regulations serves as a major driver for the expansion of the Global Salmonella Testing Market. Regulatory authorities across the globe are setting lower tolerance thresholds and implementing "zero-tolerance" mandates for specific serotypes, which compels manufacturers to implement highly sensitive molecular screening protocols. This legislative environment forces food processors to transition from traditional culture methods to sophisticated automated systems to guarantee compliance and prevent expensive operational shutdowns. For instance, the USDA Food Safety and Inspection Service finalized a policy in April 2024 declaring that raw breaded stuffed chicken products containing as little as 1 colony forming unit per gram of Salmonella are considered adulterated, a mandate that directly necessitates the acquisition of diagnostic assays capable of detecting low-level contamination with extreme accuracy.

Simultaneously, the rising incidence of Salmonella outbreaks and foodborne diseases sustains the demand for rapid pathogen testing throughout the supply chain. As global food trade widens, the potential for cross-contamination increases, resulting in frequent large-scale recalls that require strict testing at critical control points. According to a November 2024 update from the Centers for Disease Control and Prevention regarding a Salmonella outbreak linked to cucumbers, a multistate investigation identified 68 infected individuals, emphasizing the ongoing threat in fresh produce. To counter these financial and reputational dangers, companies are strengthening their verification programs; the Sedgwick "2024 Recall Index report" from May 2024 noted that FDA food recalls rose by 27.6 percent in the first quarter of 2024 compared to the prior quarter, highlighting the essential need for strong pathogen detection infrastructure.

Market Challenges

The substantial operational expenditure associated with advanced molecular diagnostic platforms represents a major obstacle to the expansion of the Global Salmonella Testing Market. These sophisticated testing systems require significant capital investment for equipment, specialized consumables, and the technical training of staff. For smaller food manufacturers and processors operating within price-sensitive markets, these expenses often surpass their financial capabilities. This economic pressure limits the broad adoption of automated detection technologies, forcing many entities to rely on labor-intensive and slower legacy methods, which in turn hampers uniform market growth in developing regions where profit margins cannot sustain such infrastructure.

This cost-related barrier directly impacts the industry's capacity to effectively manage pathogen risks, as reliance on cheaper, slower diagnostic methods can retard the identification of contaminated products. In 2024, the Centers for Disease Control and Prevention monitored and investigated 10 separate multistate Salmonella outbreaks associated with various food items, illustrating the continuing volatility of pathogen control. The inability of smaller market players to afford and implement rapid, high-precision testing systems generates vulnerabilities within the global supply chain, ultimately stifling the broader market potential for advanced diagnostic solutions.

Market Trends

The extensive adoption of Whole Genome Sequencing (WGS) is transforming the Global Salmonella Testing Market by supplanting traditional phenotypic subtyping techniques with high-resolution genomic analysis. Laboratories are increasingly employing WGS to identify serotypes, virulence factors, and antimicrobial resistance profiles within a single assay, thereby greatly improving the accuracy of source tracking during contamination incidents. This technological evolution is bolstered by distributed networks that facilitate real-time cross-border data sharing to more effectively identify outbreak origins; for example, the FDA's "GenomeTrakr Fast Facts" from December 2025 indicates that the network is now routinely sequencing over 20,000 isolates monthly, showcasing the massive scale of integrating advanced genomic technology into standard food safety surveillance.

In parallel, there is a growing demand for multiplex pathogen detection panels, which allow for the simultaneous identification of multiple Salmonella strains and co-infections in a single test run. This trend is accelerating the shift from manual culture techniques to automated molecular platforms that provide streamlined workflows and faster turnaround times for syndromic testing. Food processors and clinical laboratories are increasingly preferring these comprehensive panels to enhance diagnostic precision and operational efficiency, a shift reflected in bioMérieux's March 2025 "2024 Financial Results," which reported a 17 percent increase in sales of BIOFIRE non-respiratory panels, including gastrointestinal testing solutions.

Key Players Profiled in the Salmonella Testing Market

• Thermo Fisher Scientific Inc.
• BioMerieux SA
• Merck KGaA
• QIAGEN N.V.
• Eurofins Scientific
• Hardy Diagnostics
• PerkinElmer AES
• Mylab Discovery Solutions Pvt. Ltd.
• Abbott Laboratories Inc.
• Biomerica, Inc.

Report Scope

In this report, the Global Salmonella Testing Market has been segmented into the following categories:

Salmonella Testing Market, by Testing Method:

• Culture-based Methods
• Molecular-based Methods
• Immunoassays

Salmonella Testing Market, by Sample Type:

• Food
• Water
• Environmental Surfaces

Salmonella Testing Market, by End User:

• Food Producers and Manufacturers
• Contract Testing Laboratories
• Government and Regulatory Bodies
• Others

Salmonella Testing Market, by Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Salmonella Testing Market.

Available Customization

The analyst offers customization according to your specific needs. The following customization options are available for the report:

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.